Package 70069-161-10

{"route": ["INTRAVENOUS"], "spl_id": "0a0b0b80-1e15-40f1-9558-8acfd564abcf", "openfda": {"upc": ["0370069161012"], "unii": ["80YS8O1MBS"], "rxcui": ["199211"], "spl_set_id": ["23daa1f8-2a07-449d-97a6-11efdb0b9836"], "manufacturer_name": ["Somerset Therapeutics, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (70069-161-01)  / 10 mL in 1 VIAL", "package_ndc": "70069-161-01", "marketing_start_date": "20190802"}, {"sample": false, "description": "10 VIAL, MULTI-DOSE in 1 CARTON (70069-161-10)  / 10 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "70069-161-10", "marketing_start_date": "20190802"}], "brand_name": "Cisatracurium Besylate", "product_id": "70069-161_0a0b0b80-1e15-40f1-9558-8acfd564abcf", "dosage_form": "INJECTION", "pharm_class": ["Neuromuscular Nondepolarizing Blockade [PE]", "Nondepolarizing Neuromuscular Blocker [EPC]"], "product_ndc": "70069-161", "generic_name": "Cisatracurium Besylate", "labeler_name": "Somerset Therapeutics, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cisatracurium Besylate", "active_ingredients": [{"name": "CISATRACURIUM BESYLATE", "strength": "2 mg/mL"}], "application_number": "ANDA209132", "marketing_category": "ANDA", "marketing_start_date": "20190802", "listing_expiration_date": "20261231"}